Wang Laboratory

Welcome to Wang Laboratory, led by Qiang Wang, PhD, at the Women's Cancer Program at Cedars-Sinai.

The lab studies the signals that control cell growth and division and how deregulation of these signals may contribute to the development of human cancers. Current areas of research include cell cycle regulation and aneuploidy, the mechanism of resistance to erbB targeted therapy and biomarkers for diagnosis and prognosis of breast and ovarian cancer. A major interest of the Wang Laboratory is to identify the signaling events that contribute to tumorigenesis and development of targeted therapy for cancer.

The Wang Laboratory is affiliated with the Pancreatic Research Program, Department of Medicine and Samuel Oschin Comprehensive Cancer Institute.